Source link : https://www.newshealth.biz/health-news/loss-of-anti-tnf-treatment-response-common-in-crohns-disease/
Approximately two-thirds of patients with Crohn’s disease who initially responded to tumor necrosis factor (TNF) inhibitors lost response by the third year of treatment, a population-based observational study showed. Fully 60% treated with infliximab (Remicade) and 68% treated with adalimumab (Humira) lost treatment response by year 3, Nicholas Kennedy, MBBS, of the University of Exeter […]
Author : News Health
Publish date : 2024-04-22 19:53:48
Copyright for syndicated content belongs to the linked Source.